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ityldistance points (Figure). The product of "a" and "b" correlated well with
the flow rate QG (AG'CWVel and QpHT (ApHrCW)(r = 0.77 and 0.86, SEE =
40.0 and 26.6 mllsec respectively), although "a" or "b" alone were not well
related to CW velocity, orifice area or maximal flow rate. In addition, when
a'b was normalized by CW velocity A'B/CW correlated well with the orifice
area determined by both Gorlin and Doppler PHT methods (R = 0.75 and r
= 0.84, SEE = 0.23 and 0.14 cm2). Our study suggests that a velocity func-
tion generated from merely 2 velocities in the flow acceleration field can be
applied to determine forward flow rate and orifice area estimates in mitral
stenosis.
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3:00
Digital Particle Image Velocimetry: A New Technique
for Verification of Color Doppler Flow Mapping Data
Robin Shandas, Morteza Gharib, David Sahn, Lilliam Valdes-Cruz. California Institute
of Technology, Pasadena, CA; The Chlidrens Hospital, Denver, CO
Many color Doppler flow mapping (CDFM) systems now provide direct ac-
cess to digital velocity and variance data, thereby promising true flow quanti-
tation. However, the accuracy of flow information thus obtained has not been
adequately verified. We used laser based Digital Particle Image Velocimetry
(DPIV) to measure two-dimensional velocity components proximal and distal
to various sized orifices (0.1 cm2 -1 cm2) for steady flows (0.2 - 3 Umin).
Immediately after the DPIV studies and without changing flow conditions,
digital CDFM velocity and variance measurements were obtained at identi-
cal proximal and distal points. CDFM/digital velocity data showed excellent
agreement with the DPIV measurements although three main discrepancies
were found: 1) CDFM velocities underestimated DPIV velocities at points of
large angulation between ultrasound beam and flow direction although an
angle correction algorithm significantly reduced this error. 2) CDFM velocity
measurements underestimated DPIVvelocities to a maximum of 48% (mean
= 21 %) at points of high velocity shear such as the jet boundary, presum-
ably due to the averaging nature and limited time envelope for CDFM ve-
locity measurements. 3) Normalized variance as a percentage of maximum
reflected Dopplersignal bandwidth (0-1 00%) provided by the COFM system
was present in significant quantity (>30%) in locations of low turbulence in-
tensity as measured by DPIV indicating substantial variation between CDFM
variance and hydrodynamic turbulence. DPIV is a promising and highly accu-
rate technique for in-vitro measurements of complex cardiac flow conditions.
DPIV also provides an ideal gold-standard for verification of CDFM data and
should lead to improved understanding of CDFM information obtained in pa-
tients.
3:15
1795-61 Comparison Between Three-Dimensional
Reconstruction and Two-Dimensional Imaging for
Evaluating Regurgitant Jets: An In Vitro Study
Zheng Gong, Xiaodong Zhou, Takahiro Shlota, Brian Sinclair. Shuping Ge,
Jinping Xu, Berthold Klas, Richard Derman, David J. Sahn. Oregon Hlth Sci Univ,
Portland, OR
The aim of our study was to investigate the applicability of the 3D recon-
struction for evaluating color Doppler regurgitant jet imaging compared to
conventional 20 color Doppler flow mapping. Methods: Steady flows (20-
80 cc/sec) were driven through a rectangular orifice (24 mm2, length ~ 8 x
width) using a steady flow pump. The regurgitant jets were imaged using
3 different Nyquist velocities (35, 52 and 78 cm/sec) with an Interspec ul-
trasound system and analyzed using 3D reconstruction with a Tomtec com-
puter. An oblique "birds eye" view from above the orifice plane gave a side
view of the flattened jet. Volumes of 3D regurgitant jets were measured and
were compared to the conventional color Doppler 20 maximal jet area. Re-
sults: The 3D reconstructions showed characteristically elongated and flaring
jet propagation for all flow conditions (Figure). Jet areas sliced parallel to the
orifice plane provided the most quantifiable jet propagation pattern. A linear
relationship between flow rates and 3D jet volumes was obtained (r = 0.91, P
< 0.001) whereas conventional 20 maximal jet areas showed a less well de-
fined relationship with actual flow rates (r = 0.87, p < 0.01). The consistency
of the relationship between flow rates and jet area in 3D volume over the
various Nyquist units was also better for 3D volumes. Conclusion: Our study
suggests that three-dimensional jet volume methods should provide more
accurate approaches for quantifying regurgitant jets than the conventional
20 jet area measurement.
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1796-1 I Non Surgical Revascularization In Carotid Arteries:
Role of Percutaneous Transluminal Angloplasty
Alfredo E. Rodriguez, Mario Fernandez, Eduardo Mele, Ernesto Peyregne, Nestor
A Perez Balino Anchorena Hospital, Buenos Aires, Argentina
The role of Percutaneous Transluminal Angioplasty (PTA) in the revascular-
ization of carotid arteries is not well established. The aim of this study was
to asses the efficacy of PTA in revascularizing patients with carotid arterial
stenosis. Thirteen consecutive patients (mean age 68 ± 7.7 years) under-
went 13 PTA procedures in the carotid arteries during September 1992 to
March 1994. The indication for revascularization was recurrent ischemic at-
tacks with severe 1>50%1 carotid stenosis in the 13 cases. Time between
symptoms onset to PTA was more than one month in all cases. The lesions
were located in the internal carotid arteries (first extracraneal segment) in
nine patients and in the common carotid arteries in four. This group included
one patient treated by severe internal carotid stenosis with complete occlus-
sion in the contralateral internal carotid vessel. PTA was performed using
conventional technique. The balloonlartery ratio was 0.8-0.9/1 in all cases
(Mean balloon size 5.3 ± 0.5 mm). Results: PTA was successfully performed
in all patients with the diameter stenosis reduced from, 77.5 ± 5% to 19.7 ±
4%. Four patients had bradycardia and hypotension during balloon inflation.
Two patients had transient neurologic deficit immediately after the proce-
dure, resolved within 24 hours. No patient had a residual neurologic deficit
upon discharge (mean 48 hours). At late clinical follow up (mean time 10 ±
7 months) one patient had restenosis with a new successful PTA. Conclu-
sion: This early experience showed that PTA can be performed successfully
and safely in selected cases of patients with symptomatic severe stenosis
in carotid arteries. However, larger groups of patients and longer follow-up
should need to compare this technique with surgical-endarterectomy.
2:15
1796-21 Application of Lessons Learned from Cardiac
Interventional Techniques to Carotid Angioplasty
(PTA)
Sanjay S. Yadav, Gary S. Roubln, Sriram Iyer, Suresh Jain, Gerald Blackwell,
Jiri Vitek, Natalia Plyuscheva, Dennis Doblars, Winfield Fisher, Gerald M. Pohost
University ofAlabama at Birmingham, Birmingham, AL
PTA of the carotid and vertebral arteries remains a challenging area of vascu-
lar intervention and optimal techniques have yet to be determined. We de-
scribe our initial experience with a novel approach to carotid PTA utilizing: 1)
"active" perfusion, as is done during coronary angioplasty, which allows pro-
longed balloon inflations without cerebral ischemia; 2) transcranial doppler
(TCD) monitoring, when anatomically feasible, during PTA to assess ante-
grade flow and detect cerebral emboli; 3) temporary pacing for bradycardia
during intra-{;arotid balloon inflation; and 4) magnetic resonance angiogra-
phy (MRA) for screening and follow-up. We have also used the previously
described "protected" carotid PTA technique using an additional occluding
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balloon to prevent cerebral emboli. Six symptomatic patients had 7 PTAs (6
carotids, 1 vertebral).
Pt. # Angioplasty Transcrania Stenosis Complications Stenosis
Technique Doppler Pre~Post 3 m F/U
1 Protected 73 emboli 90%--.20% none 10%
2 Protected 40 emboli 90%~ 0% none 0%
3 Active Perf. no window 95%~O% none 0%
4 Active Perf. 10 emboli 99%---+0% none 0%
5 Active Perf. no window 99%--+0% hemorrh--.death
6 Standard no window 100%-+30%-+ none pendin9
(vertebral) 5tent-+0%
Active Perf. 70%--)o-dissec, none pending
(carotid) 20%-+ 5tent--+ 0%
Maintenance of cerebral perfusion during PTA by "active" perfusion and
cardiac pacing allows prolonged balloon inflations which minimize residual
stenosis; when feasible, TCD monitoring is a valuable adjunct. Ongoing stud-
ies with more patients will elucidate the value of this approach for carotid
angioplasty.
2:30
Treatment of Superficial Femoral Artery Occlusion by
Percutaneous Revascularizatlon of Ipsilateral Iliac
Artery Stenosis
Waqar Khan, Robert Schainfeld, Ann Pieczek, Kenneth Rosenfield, Jeffrey M. Isner.
St. Elizabeth's Medical Center, Boston, MA Tufts University School of Medicine, Boston,
MA
Systolic Blood Pressure
N Baseline 24 hr 1 mo 6 mo
Total cohort 39 177 ± 22 138 ± 20* 158 ± 30** 152 ± 25*
Responders (R) 25 184 ± 22 140 ± 23* 160 ± 32* 143 ± 21*
Non-responders (NR) 14 166 ± 19 134± 11* 157 ± 30 167 ± 25
*p < 0.0001, **p < 0.001 versus baseline BP
A significant (:::15%) improvement in SBP and/or DBP was measured in
86% of all patients 24 hours after stent implantation. At one and 6 months,
63% had sustained improvement in both SBP and DBP and were long-term
responders. A sustained BP improvement 6 months after stenting was pre-
dicted by older patient age, more severe hypertension, and larger reference
vessel diameter (p < 0.05). Not predictive of a favorable response to stent-
ing was sex, number of HTN medications, unilateral versus bilateral disease,
baseline serum Cr, BUN, or 6 month angiographic (:::50% diameter) resteno-
sis.
Conclusion: Renal artery stenting results in immediate BP control in the
majority patients studied, however, this BP improvement is sustained in only
63% of patients. Multi-variant analysis indicates that older patients with more
severe hypertension and larger renal arteries are more likely to receive a sus-
tained benefit from renal artery stenting.
3:00
1796-5\ Stentlng of Renal Artery Stenosis: One-Year Followup
Tanvir K. Bajwa, Yoseph Shalev, Donald H. Schmidt University of Wisconsin,
Milwaukee, WI
*p < 0.05; values listed are pre- and 12 months post-procedure
No RestenosisBilateralUnilateral
Central vein occlusion is a common cause of morbidity in patients with up-
per extremity hemodialysis (HD) access sites and a history of ipsilateral in-
dwelling central lines. We analyzed the results of two percutaneous treat-
ments, balloon angioplasty (PTA) and stenting (S) that were used to relieve
symptomatic venous occlusion (arm edema, pain) and improve dialysis effi-
ciency (venous pressure and recirculation fraction). Group I consisted of 26
patients (13 men, 13 women, mean age ~ 62 ± 14.3), with de novo lesions
(innominate = 5, subclavian = 21) who underwent PTA. Group II consisted of
13 patients from Group I who underwent stent implantation (6 Palmaz stents,
7 Wallstents) for failed PTA due to suboptimal angioplasty results (n = 5) or
restenosis In = 8). We retrospectively compared the acute and long-term
clinical success and restenosis rates in these two treatment groups. Acute
success was defined as resolution of symptoms and resumption of dialy-
sis. Restenosis was defined as >50% stenosis by angiography. Long-term
success @ mean follow-up 14 months was defined as continued dialysis
without symptomatic venous occlusion or dialysis graft failure.
3:15
Comparison of Stenting and PTA for Central Venous
Stenosis In Hemodialysis Patients
Peter Wassmer, Shabblr Dharamsey, Reynaldo Mulingtapang, SylVia Griffin,
Sam Money, Stephen Jenkins, Christopher White, Stephen Ramee. Ochsner Clinic,
New Orleans. LA; Health Care International, Glasgow, Scotland
Complications: Two patients developed pseudoaneurysm of left brachial
artery, which required percutaneous closure.
Conclusions: 1) Renal artery stenting can be performed with a low com-
plication rate, 2) In the majority of patients, symptomatic improvement was
achieved and maintained over a 12-month period and the number of antihy-
pertensive medications required decreased, and 3) Based on our study, we
would recommend renal artery stenting as the therapeutic option of choice
for symptomatic renal artery stenosis.
Creatinine (mg%) 2.1 ± 1.1 to 15 ± 0.9 2.5 ± 0.7 to 1.5 ± 0.6 2.1 ± 0.6 to 1.5
Diastolic BP ImmHg) 95 ± 10 to 80± S* 9O± 9 to SO ± 5* 90±7 to SO± 2*
No. of Meds. 3.2 ± 1to 1.1 ± 09* 2.9 ± 1 to 20 ± 0.5* 3.1 ± 1to 1.5 ± 1.0'
Palmaz-Schatz stents were deployed in 55 renal arteries (articulated in 30 and
nonarticulated in 25) of 45 pts (35 unilateral. 10 bilateral). Forty of the patients
were male and 5 were female (mean age 65 ± 5 years). 20/45 (44%) pts had
associated diabetes mellitus and coronary artery disease. We retrospectively
analyzed clinical outcome (renal functions, blood pressure, and number of
antihypertensive medications) at 6 and 12 months. Six month angiographic
followup was available in 25/45 pts (56%) and showed a restenosis rate of
5/25 (20%).
To evaluate the acute and chronic blood pressure (BP) response after renal
artery stent implantation, we prospectively studied 39 patients (14 men, 25
women, mean age = 67 ± 1O) with hypertension IHTN) refractory to medical
therapy and atherosclerotic renal artery stenosis I:::70%) who were treated
with balloon angioplasty and deployment of a stainless steel, non-articulated,
balloon expandable Palmaz stent. Twenty three (59%) patients had unilateral
stenosis, 14 (36%) had bilateral disease, and 2 (5%) had a solitary kidney. The
mean number of anti-hypertensive medications was 2.5 before treatment.
BP was recorded at baseline, 24 hrs., and at 1, 3, and 6 months after stent
implantation. Patients were classified either as responders (R), defined as
a ::: 15% drop in systolic (SBP) and/or diastolic blood pressure (DBP) from
baseline Bp, or non-responders (NR) based on their 6 month BP result.
2:45
Acute and Long-term Effect of Renal Artery Stentlng
on Blood Pressure Control In Patients with
Atherosclerotic Renovascular Hypertension
Dinesh Shaw, Christopher White, Tyrone Collins, Arun Karsan, Melissa Facundus,
Richard Milani, Stephen Ramee. Ochsner Clinic, New Orleans; Health Care
International, Glasgow, Scotland
The acute and long-term results of percutaneous revascularization of the
lower extremities are typically superior for inflow (iliac) than distal (super-
ficial femoral artery SFA, popliteal, or infrapopliteal disease). Accordingly, we
investigated the utility of performing percutaneous revascularization for only
inflow (iliac) lesions in pts with both inflow as well as distal disease. We
treated 43 limbs in 36 pts (28 M, 8 F, age mean ± SD = 69 ± 8 yrs) with
the combination of SFA occlusion and ipsilateral iliac artery lesions by percu-
taneous revascularization of the iliac artery lesion only. Ten lesions involved
the common iliac artery, 18 involved both the common and the external iliac
arteries, and 15 consisted of external iliac artery stenosis. All pts were symp-
tomatically Rutherford class 3 and/or above. Mean ankle-brachial index (ABI)
pre-procedure was 0.55 ± 0.19. Ipsilateral iliac artery stenosis, determined
by quantitative angiography, was 80 ± 12%. All iliac lesions were treated
with percutaneous transluminal angioplasty (PTA) ± stent placement. Post-
PTA, iliac artery stenosis decreased to 8 ± 8%. Of the 43 treated limbs, 40
(93%) were associated with improvement by at least one Rutherford class.
One month post-procedure, mean ABI improved to 0.63 ± 0.191p < 0.009).
Complications were limited to 1 instance of arterial dissection which was
successfully treated with a stent. Six-month follow-up was available on 24/43
limbs; 19/24 (79%) continued to show improved symptoms measured by
Rutherford class. ABI's were remeasured at six months in 22 pts, and 18/22
(82%) showed improved ABI compared to baseline. Conclusion: Percuta-
neous revascularization limited to iliac artery stenosis in patients with ipsilat-
eral superficial femoral artery occlusion, by augmenting arterial inflow via a
patent profunda, is frequently sufficie'1t to produce clinical improvement of
disabling symptoms.
